| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altered gene expression of miR-155 in peripheral blood mononuclear cells of Multiple sclerosis patients: Correlation with TH17 frequency, inflammatory cytokine profile and autoimmunity
|
Alipour, Shiva
|
|
|
89 |
C |
p.
|
artikel
|
| 2 |
An analytical review on the use of artificial intelligence and machine learning in diagnosis, prediction, and risk factor analysis of multiple sclerosis
|
Pilehvari, Shima
|
|
|
89 |
C |
p.
|
artikel
|
| 3 |
A preliminary investigation of sex differences in cognitive and fMRI changes following 28 days of cannabis abstinence
|
Meza, Cecilia
|
|
|
89 |
C |
p.
|
artikel
|
| 4 |
A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement
|
Straus Farber, Rebecca
|
|
|
89 |
C |
p.
|
artikel
|
| 5 |
A randomized, double-blind, placebo-controlled trial to evaluate the effect of nabiximols oromucosal spray on clinical measures of spasticity in patients with multiple sclerosis
|
Bethoux, Francois A.
|
|
|
89 |
C |
p.
|
artikel
|
| 6 |
Carotid intima media thickness and multiple sclerosis
|
Saleh, Christian
|
|
|
89 |
C |
p.
|
artikel
|
| 7 |
Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis
|
Fuchs, Tom A.
|
|
|
89 |
C |
p.
|
artikel
|
| 8 |
Comparing the effectiveness, safety and tolerability of interventions for depressive symptoms in people with multiple sclerosis: A systematic review
|
Campese, Stephanie
|
|
|
89 |
C |
p.
|
artikel
|
| 9 |
Diversity and representation within the literature on sexual dysfunction in multiple sclerosis: A systematic review
|
Zaloum, Safiya A
|
|
|
89 |
C |
p.
|
artikel
|
| 10 |
Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients
|
Torgauten, Hilde M.
|
|
|
89 |
C |
p.
|
artikel
|
| 11 |
Japanese translation and validation of the 12-item Multiple Sclerosis Walking Scale version 2
|
Miyazaki, Yusei
|
|
|
89 |
C |
p.
|
artikel
|
| 12 |
Mr. Machiavelli's Choice for Treatment of MOG Antibody Disease: Do the benefits of long-term corticosteroids justify the means?
|
Levy, Michael
|
|
|
89 |
C |
p.
|
artikel
|
| 13 |
Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric study
|
Krbot Skorić, Magdalena
|
|
|
89 |
C |
p.
|
artikel
|
| 14 |
Projected number of people with multiple sclerosis in Germany between 2015 and 2040
|
Baginski, Kira
|
|
|
89 |
C |
p.
|
artikel
|
| 15 |
Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up
|
Ayrignac, Xavier
|
|
|
89 |
C |
p.
|
artikel
|
| 16 |
The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis
|
Tan, Yin Yin
|
|
|
89 |
C |
p.
|
artikel
|
| 17 |
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)
|
Carnero Contentti, Edgar
|
|
|
89 |
C |
p.
|
artikel
|
| 18 |
Trends in mortality due to multiple sclerosis in the United States: A retrospective analysis from 1999 to 2020
|
Nadeem, Zain Ali
|
|
|
89 |
C |
p.
|
artikel
|
| 19 |
Worsening of lymphopenia in patients with multiple sclerosis when switched from dimethyl fumarate to diroximel fumarate
|
Dempsey, John Patrick
|
|
|
89 |
C |
p.
|
artikel
|
Tijdschrift beschrijving